Raymond James Financial Inc Sangamo Therapeutics, Inc Transaction History
Raymond James Financial Inc
- $280 Billion
- Q2 2025
A detailed history of Raymond James Financial Inc transactions in Sangamo Therapeutics, Inc stock. As of the latest transaction made, Raymond James Financial Inc holds 15,544 shares of SGMO stock, worth $8,860. This represents 0.0% of its overall portfolio holdings.
Number of Shares
15,544
Previous 16,544
6.04%
Holding current value
$8,860
Previous $10,000
20.0%
% of portfolio
0.0%
Previous 0.0%
Shares
2 transactions
Others Institutions Holding SGMO
# of Institutions
124Shares Held
51.1MCall Options Held
1.12MPut Options Held
789K-
Vanguard Group Inc Valley Forge, PA9.37MShares$5.34 Million0.0% of portfolio
-
Wasatch Advisors Inc Salt Lake City, UT8.08MShares$4.61 Million0.02% of portfolio
-
Jim Simons Renaissance Technologies LLC | New York, Ny6.84MShares$3.9 Million0.01% of portfolio
-
Black Rock Inc. New York, NY4.7MShares$2.68 Million0.0% of portfolio
-
Geode Capital Management, LLC Boston, MA2.33MShares$1.33 Million0.0% of portfolio
About SANGAMO THERAPEUTICS, INC
- Ticker SGMO
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 156,552,992
- Market Cap $89.2M
- Description
- Sangamo Therapeutics, Inc., a clinical-stage biotechnology company, focuses on translating science into genomic medicines that transform patients' lives using platform technologies in gene therapy, cell therapy, genome editing, and genome regulation. The company offers zinc finger protein (ZFP), a technology platform for making zinc finger nucle...